Skip to main content
. 2021 Nov 6;2021(11):CD001800. doi: 10.1002/14651858.CD001800.pub4

3. Results for univariate meta‐regression for all‐cause mortality.

Explanatory variable (n trials) Exp (slope)* 95% confidence interval,P value Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 46) RR = 1.00 1.00 to 1.00, P = 0.15 56.1% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 33) RR = 1.00 1.00 to 1.00, P = 0.11  
 
100%
No evidence that risk ratio is associated with type of CR
Duration of follow‐up (months) (n = 47) RR = 1.00 1.00 to 1.00, P = 0.07 100% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 47) RR = 1.04 0.84 to 1.31, P = 0.70 ‐27.1% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 47) RR = 0.84 0.70 to 0.99, P = 0.04 100% No evidence that risk ratio is associated with publication year
CR setting (n = 47) RR = 0.95 0.82 to 1.24, P = 0.95 ‐11.3% No evidence that risk ratio is associated with type of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 47) RR = 1.02 0.94 to 1.09, P = 0.67 ‐68.55% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 47) RR = 1.01 0.86 to 1.19, P = 0.93 ‐41.24% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high‐income country (n = 47) RR = 1.02 0.70 to 1.48, P = 0.93 ‐45.10% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 47) RR = 1.19 0.73 to 1.93, P = 0.47 16.07% No evidence that risk ratio is associated with study sample size